Seattle startup TwinStrand raises $50M to expand tech that identifies rare genetic mutants
Jesse Salk, CEO and Co-Founder of TwinStrand Biosciences. (TwinStrand photo) New financing: Gene sequencing startup TwinStrand Biosciences raised $ 50 million in a Series B round led by Section 32, a California-based fund focused on biotechnology, technology, healthcare and life sciences. All venture capital funding for the 6-year-old company is now north of $ 70 … Read more